Post-Traumatic Stress Disorder (PTSD) Pipeline Review, H1 2019 by: Actinogen Medical Ltd, Addex Therapeutics Ltd, Amorsa Therapeutics Inc, Anagin Inc, Aptinyx Inc, Armgo Pharma Inc, Artelo Biosciences Inc, Azevan Pharmaceuticals Inc, Catalyst Pharmaceutic

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2019.

Summary:

Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by a terrifying event either experiencing it or witnessing it. Symptoms include flashbacks, nightmares and severe anxiety, as well as uncontrollable thoughts about the event. Treatment includes antidepressants, anti-anxiety and cognitive therapy.

Report Highlights:

Post-Traumatic Stress Disorder (PTSD) market based on elite players, present, past and futuristic data which will offer as a profitable guide for all Post-Traumatic Stress Disorder (PTSD) Market competitors. The overall analysis Post-Traumatic Stress Disorder (PTSD) covers an overview of the industry policies, the cost structure of the products available in the market, and their manufacturing chain. Global Post-Traumatic Stress Disorder (PTSD) Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Post-Traumatic Stress Disorder (PTSD) industry.

Get Sample Copy of this Report at https://bit.ly/2GAJS56

Pharmaceutical and Healthcare latest pipeline guide Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Post-Traumatic Stress Disorder (PTSD) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Traumatic Stress Disorder (PTSD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 4, 19, 6 and 2 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 3 and 1 molecules, respectively.

The Post-Traumatic Stress Disorder (PTSD) Market report profiles the following companies, which includes: Actinogen Medical Ltd, Addex Therapeutics Ltd, Amorsa Therapeutics Inc, Anagin Inc, Aptinyx Inc, Armgo Pharma Inc, Artelo Biosciences Inc, Azevan Pharmaceuticals Inc, Catalyst Pharmaceuticals Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Eli Lilly and Co, Embera NeuroTherapeutics Inc, Immodulon Therapeutics Ltd, Johnson & Johnson, Lixte Biotechnology Holdings Inc, NeuroNascent Inc, Omeros Corp, Otsuka Holdings Co Ltd, Sanofi, SpringWorks Therapeutics LLC, Tonix Pharmaceuticals Holding Corp.

Geographical Regions of Post-Traumatic Stress Disorder (PTSD) Market: United States of America, Canada, Mexico, Rest of North America. Brazil, Argentina, Rest of South America, China, Japan, India, Rest of Asia-Pacific, United Kingdom, Germany, France, Rest of Europe, UAE, South Africa, Saudi Arabia.

Get Discount Now at https://bit.ly/2StMnNB

TABLE OF CONTENTS:

Table of Contents
Introduction
Post-Traumatic Stress Disorder (PTSD) - Overview
Post-Traumatic Stress Disorder (PTSD) - Therapeutics Development
Post-Traumatic Stress Disorder (PTSD) - Therapeutics Assessment
Post-Traumatic Stress Disorder (PTSD) - Companies Involved in Therapeutics Development
Post-Traumatic Stress Disorder (PTSD) - Drug Profiles
Post-Traumatic Stress Disorder (PTSD) - Dormant Projects
Post-Traumatic Stress Disorder (PTSD) - Discontinued Products
Post-Traumatic Stress Disorder (PTSD) - Product Development Milestones
Appendix

Reasons to Buy:

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Post-Traumatic Stress Disorder (PTSD) (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

About us: -

Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in today's competitive world.

Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you.

So whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Contact Us:

sales@reportsintellect.com
PH - + 1-888-259-6883
US Address: -
225 Peachtree Street NE,
Suite 400,
Atlanta, GA 30303

This release was published on openPR.